News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Joshua Brody: Crystal-Clear Update on Treating Aggressive Lymphomas
Joshua Brody/LinkedIn
Jul 10, 2025, 20:21

Joshua Brody: Crystal-Clear Update on Treating Aggressive Lymphomas

Joshua Brody, Associate Professor of Division of Hematology and Oncology at Icahn School of Medicine at Mount Sinai, shared on LinkedIn:

“Great, crystal-clear update on treating aggressive lymphomas e.g. DLBCL in Community Oncology centers and opportunities for collaboration with Lymphoma specialists. ”

Aggressive Lymphomas cancer DLBCL Joshua Brody lymphoma OncoDaily Oncology
Special Coverage
Blog
Jul 10, 2025, 20:21
Joshua Brody: Crystal-Clear Update on Treating Aggressive Lymphomas
Insight
Jul 10, 2025, 20:08
Pashtoon Kasi: The 1st Agnostic Study of a PARP Inhibitor
Drugs
Jul 10, 2025, 16:59
Taletrectinib (Ibtrozi): What Patients Should Know About in 2025?
Blog
Jul 10, 2025, 16:30
Indiana’s First Mobile Lung Screening Unit Proves That Access to Care Saves Lives - IU Simon Comprehensive Cancer Center
Blog
Jul 10, 2025, 16:24
Herbert Loong: Had an Opportunity to Introduce and Discuss Soft Tissue Sarcomas at Radio Television Hong Kong
Blog
Jul 10, 2025, 16:14
Sebastian Other-Gee Pohl Completed 2 Years of EACR-Boehringer Ingelheim Postdoctoral Fellowship
Blog
Jul 10, 2025, 16:11
Heba Bakri: Honored to Welcome Assiut University Heamtology Team for a Discussion on Multiple Myeloma Management
Blog
Jul 10, 2025, 16:00
Mahul B Amin: Honored to Contribute 11th Edition of Robbins and Cotran Pathology Textbook
Science
Jul 10, 2025, 15:44
Justin Yeung: Patient Reported Outcome Measures in the Treatment of Colorectal Cancer
Celebrities
Jul 10, 2025, 15:23
King Albert II’s Brave Battle: A Decade of Fighting Skin Cancer
Oncolibrary
Jul 10, 2025, 15:13
Bladder Cancer Chemotherapy Success Rate: What Patients Need to Know in 2025
Science
Jul 10, 2025, 15:12
Luisa Soares Miranda: Excited to Share our Latest Publication on Trastuzumab Deruxtecan in Previously Treated HER2-Low MBC